MBP and Behcet disease: In BD patients, we observed a tendency towards a decrease in the level of proteolytic activity with disease duration over 5 years (p < 0.053), along with a decrease in the affinity of MBP-hydrolyzing antibodies, according to the analysis of the kinetic parameters.